Sotac Pharma.

{
  "main_header": {
    "sid": 1003827,
    "name": "Sotac Pharma.",
    "stock_name": "Sotac Pharma.",
    "full_name": "Sotac Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/sotac-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "109.25",
    "chg": -5.75,
    "chgp": "-5.0%",
    "dir": -1,
    "prev_price": "115.00",
    "mcapval": "127.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "SOTAC",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0O2D01012",
    "curr_date": "Mar 30",
    "curr_time": "",
    "bse_nse_vol": 1200,
    "exc_status": "Active",
    "traded_date": "Mar 30, 2026",
    "traded_date_str": "2026 03 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sotac-pharma-1003827-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sotac Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3924616",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SotacPharmaceut_stocks_hitting_lower_circuit_3924616.png",
        "date": "2026-03-30 12:00:11",
        "description": "At Rs 109.25, sellers were still queuing — but there were no buyers willing to take the other side. Sotac Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 30 Mar 2026, with unfilled sell orders and a frozen price, reflecting a constrained exit environment for shareholders."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-strong-sell-3917911",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SotacPharmaceut_mojoScore_3917911.png",
        "date": "2026-03-26 10:10:14",
        "description": "Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-strong-sell-3892161",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SotacPharmaceut_mojoScore_3892161.png",
        "date": "2026-03-15 10:10:12",
        "description": "Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3882948",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SotacPharmaceut_stocks_hitting_upper_circuit_3882948.png",
        "date": "2026-03-10 14:00:12",
        "description": "Sotac Pharmaceuticals Ltd witnessed a robust surge in its share price on 10 Mar 2026, hitting the upper circuit limit of 5.0% to close at ₹116.55. This sharp rally was driven by intense buying interest, resulting in a maximum permissible daily gain and a regulatory freeze on further trading, underscoring the stock’s heightened demand despite its micro-cap status and recent downgrade to a Strong Sell rating."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-strong-sell-3866299",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SotacPharmaceut_mojoScore_3866299.png",
        "date": "2026-03-03 10:10:13",
        "description": "Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 January 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 03 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-strong-sell-3848235",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SotacPharmaceut_mojoScore_3848235.png",
        "date": "2026-02-20 10:10:20",
        "description": "Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 February 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3845804",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SotacPharmaceut_stocks_hitting_lower_circuit_3845804.png",
        "date": "2026-02-18 11:00:13",
        "description": "Sotac Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 18 Feb 2026, hitting its lower circuit price limit of ₹118.75. The stock plunged by 5.0% in a single trading session, reflecting intense selling pressure and panic among investors amid subdued market sentiment and falling participation."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3830339",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SotacPharmaceut_stocks_hitting_upper_circuit_3830339.png",
        "date": "2026-02-10 10:01:16",
        "description": "Sotac Pharmaceuticals Ltd witnessed a remarkable surge on 10 Feb 2026, hitting its upper circuit limit of ₹124.20, marking a maximum daily gain of 4.99%. This sharp price movement was driven by robust buying interest, resulting in a regulatory trading freeze and highlighting significant unfilled demand in the micro-cap pharmaceutical stock."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-strong-sell-3828526",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SotacPharmaceut_mojoScore_3828526.png",
        "date": "2026-02-09 10:10:30",
        "description": "Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 January 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 09 February 2026, providing investors with the latest perspective on the company’s position."
      }
    ],
    "total": 325,
    "sid": "1003827",
    "stock_news_url": "https://www.marketsmojo.com/news/sotac-pharmaceuticals-1003827"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sotac Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sotac Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight

2026-03-30 12:00:11

At Rs 109.25, sellers were still queuing — but there were no buyers willing to take the other side. Sotac Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 30 Mar 2026, with unfilled sell orders and a frozen price, reflecting a constrained exit environment for shareholders.

Read full news article

Sotac Pharmaceuticals Ltd is Rated Strong Sell

2026-03-26 10:10:14

Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Sotac Pharmaceuticals Ltd is Rated Strong Sell

2026-03-15 10:10:12

Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Sotac Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-03-10 14:00:12

Sotac Pharmaceuticals Ltd witnessed a robust surge in its share price on 10 Mar 2026, hitting the upper circuit limit of 5.0% to close at ₹116.55. This sharp rally was driven by intense buying interest, resulting in a maximum permissible daily gain and a regulatory freeze on further trading, underscoring the stock’s heightened demand despite its micro-cap status and recent downgrade to a Strong Sell rating.

Read full news article

Sotac Pharmaceuticals Ltd is Rated Strong Sell

2026-03-03 10:10:13

Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 January 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 03 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Sotac Pharmaceuticals Ltd is Rated Strong Sell

2026-02-20 10:10:20

Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 February 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Sotac Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure

2026-02-18 11:00:13

Sotac Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 18 Feb 2026, hitting its lower circuit price limit of ₹118.75. The stock plunged by 5.0% in a single trading session, reflecting intense selling pressure and panic among investors amid subdued market sentiment and falling participation.

Read full news article

Sotac Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-02-10 10:01:16

Sotac Pharmaceuticals Ltd witnessed a remarkable surge on 10 Feb 2026, hitting its upper circuit limit of ₹124.20, marking a maximum daily gain of 4.99%. This sharp price movement was driven by robust buying interest, resulting in a regulatory trading freeze and highlighting significant unfilled demand in the micro-cap pharmaceutical stock.

Read full news article

Sotac Pharmaceuticals Ltd is Rated Strong Sell

2026-02-09 10:10:30

Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 January 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 09 February 2026, providing investors with the latest perspective on the company’s position.

Read full news article

View All News